Homocysteine and Cognitive Function
|
|
- Camron Little
- 6 years ago
- Views:
Transcription
1 Homocysteine and Cognitive Function Aron Troen, Ph.D., 1 and Irwin Rosenberg, M.D. 1 ABSTRACT The prevention and treatment of age-related cognitive impairment and dementia is one of the greatest and most elusive challenges of our time. The prevalence of dementia increases exponentially with age, as does the prevalence of those with micronutrient deficiency. Several studies have shown that elevated homocysteine is correlated with cognitive decline and with cerebral atrophy and that it predicts the subsequent development of dementia in cognitively intact middle-aged and elderly individuals. If elevated homocysteine promotes cognitive dysfunction, then lowering homocysteine by means of B-vitamin supplementation may protect cognitive function by arresting or slowing the disease process. KEYWORDS: Homocysteine, cognitive function, dementia Q1 Educational Objectives: Q1 The prevention and treatment of age-related cognitive impairment and dementia is one of the greatest and most elusive challenges of our time. The prevalence of dementia increases exponentially with age from less than 1% at age 60 years to one in every three individuals by age In addition, many other people experience less severe manifestations of mild cognitive impairment without progressing to frank dementia. The onset of dementia is insidious, and the underlying pathologies are believed to be active for many years before the cognitive loss becomes apparent; however, once apparent, brain damage may be irreversible. 2 It is therefore of the utmost importance to evaluate strategies to prevent or slow agerelated cognitive decline. Several studies have reported that elevated homocysteine is correlated with cognitive decline and with cerebral atrophy, 3 and it predicts the subsequent development of dementia 4 in cognitively normal, middle-aged and elderly individuals. If indeed homocysteine promotes cognitive dysfunction, then lowering homocysteine levels by means of B-vitamin supplementation may protect cognitive function by arresting or slowing the disease process. 5 Many studies have reported associations between elevated plasma homocysteine and cognitive dysfunction. Elevated plasma total homocysteine (thcy) has consistently and convincingly been linked with diseases of the aging brain, including subtle age-related cognitive decline, cerebrovascular disease and stroke, 7 10 Vascular Dementia, 11,12 and Alzheimer disease. 4,13 The appearance of homocysteine as a common denominator in several age-related central nervous system disorders indicates that homocysteine may represent a common pathophysiological pathway in these conditions. ELEVATED thcy AND STROKE Many case control and cross-sectional studies have reported a positive association between hyperhomocysteinemia 204 Homocysteine, B-Vitamins, and Risk of Cardiovascular Disease; Editor in Chief, Jan Jacques Michiels, M.D., Ph.D.; Guest Editors, Robert Clarke, M.D., Yvo Smulders, Ph.D., Brian Fowler, Ph.D., and Coen D.A. Stehouwer, M.D. Seminars in Vascular Medicine, Volume 5, Number 2, Address for correspondence and reprint requests: Aron Troen, Ph.D., Nutrition and Neurocognition Laboratory and Vitamin Metabolism and Aging Laboratory, The Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts. 1 Nutrition and Neurocognition Laboratory and Vitamin Metabolism and Aging Laboratory, The Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA Copyright # 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY USA. Tel: +1(212) ,p;2005,05,02,204,209,ftx,en;svm00236x.
2 HOMOCYSTEINE AND COGNITIVE FUNCTION/TROEN, ROSENBERG 205 and stroke and heart disease. A metaanalysis of 27 case control studies reported an odds ratio for cerebrovascular disease of 1.9 per 5 mm increase in thcy, 10 whereas another reported an odds ratio of 3.97 for a thcy level above the 95th percentile. 14 Although some prospective studies failed to confirm these observations, most reported significant associations between elevated homocysteine and risk of stroke. 8,18 20 The Framingham study of 1947 older people reported an odds ratio of 1.82 (95% confidence interval [CI] ) for the highest compared with the lowest quartile of homocysteine in a 9.9-year follow up. 8 A metaanalysis of the C677T polymorphism for the methyletetrahydrofolate reductase gene and risk of stroke involving 13,928 individuals reported an odds ratio of 1.26 for those with the TT genotype compared with those with the CC genotype. This TT genotype results in a higher homocysteine level, which provides some support for causality. 21 ELEVATED thcy AND DEMENTIA The publication of three cross-sectional studies in that reported on the association of elevated homocysteine with Alzheimer disease prompted a substantial increase in interest in the homocysteine hypothesis of Alzheimer disease. 13,22,23 Since then, a small number of studies have not observed this association, but many more studies have confirmed these observations The strongest associations were reported by Clarke et al. in a longitudinal case control study comparing homocysteine levels taken during life from 76 cases with a histological diagnosis of Alzheimer disease made postmortem and 108 controls without cognitive impairment. 13 Clarke et al. reported an odds ratio of 4.5 (95% CI ) for histologically confirmed Alzheimer disease associated with homocysteine in the upper compared with the lower third, after controlling for age, sex, smoking, social class, and ApoE genotype. When folate and B 12 were controlled for, in addition to the other variables, the odds ratio increased to 5.1, indicating that the effects of homocysteine may be independent of vitamin status. In the latter study, homocysteine values were measured annually and were found to be relatively stable during follow-up, compared with values at enrollment, and homocysteine levels appeared to be independent of the duration of illness or severity of dementia before enrollment. Moreover, elevated homocysteine predicted the extent of medial temporal lobe atrophy, as assessed on a computed tomography scan of dementia patients. 13 Several studies of clinically diagnosed Alzheimer disease correlated homocysteine with the severity of cognitive impairment; 23,29 however, without histological confirmation, one cannot exclude the possibility that the more severely impaired cases did not have concomitant vascular disease. Indeed, Alzheimer and cerebrovascular disease frequently overlap, and the presence of vascular pathology contributes synergistically to the severity of cognitive impairment beyond what would be predicted on the basis of the Alzheimer pathology alone. 37 High levels of homocysteine are also found in studies of non- Alzheimer-type Vascular Dementia. 7,11,29,30,38 Given its association with other forms of cardiovascular and peripheral vascular disease, homocysteine might play a role in the pathogenesis of vascular dementia through brain infarctions or white-matter changes (leukoencephalopathy) from small vessel disease. 12 Fassbender et al. found that mean plasma thcy was higher in subcortical vascular encephalopathy that was associated with what he defined as microvessel disease (mean SD mm thcy) than in association with large-vessel disease (mean mm). 39 In this study, plasma homocysteine was a stronger risk factor for subcortical vascular dementia than was age, hypertension, diabetes, or smoking, with an odds ratio of 5.7 (95% CI ). 11 The most compelling evidence to date comes from a prospective study of 1092 dementia-free elderly individuals from the Framingham cohort. This study reported that baseline hyperhomocysteinemia (thcy > 14 mm) was associated with almost double the risk of dementia and of Alzheimer s disease over an 8-year follow-up period. 4 Using multivariate proportional hazards regression analysis to adjust for age, sex, apolipoprotein-e genotype, and vascular risk factors other than homocysteine and plasma levels of folate and vitamins B 12 and B 6, the relative risk for dementia was 1.4 (95% CI ) per standard deviation increase in either baseline or follow-up plasma homocysteine. The corresponding relative risks for Alzheimer disease were even higher, at 1.7 (95% CI ) for baseline and 1.5 (95% CI ) for follow-up. In other words, a 5-mM increase in plasma homocysteine levels at baseline increased the risk of development of dementia by 40 70%. The risk of Alzheimer disease attributable to a plasma thcy in the highest age-specific quartile of our population was 16%, which is comparable to the population-attributable risk of having at least one apolipoprotein-e e4 allele (22%). 40 Nevertheless, these data have yet to be replicated. A recent attempt to do so in 679 subjects of the Washington Heights Inwood Columbia Aging study found no association between baseline homocysteine and subsequent risk of dementia or cognitive decline. 25 However, in comparison to the Framingham study, subjects had lower educational levels, a higher prevalence of diabetes, a narrower range of homocysteine levels, and a shorter mean follow-up time, all of which might have lessened the likelihood of detecting a significant association. HOMOCYSTEINE AND MILD COGNITIVE IMPAIRMENT Several cross-sectional studies conducted by our group and many others 29,44 46 in dementia-free
3 206 SEMINARS IN VASCULAR MEDICINE/VOLUME 5, NUMBER subjects have shown a correlation between elevated plasma homocysteine and poor performance on neuropsychological tests. One study of 156 community-dwelling, self-caring, nondemented elderly found that Cambridge Cognitive Examination scores were inversely related to thcy values, even after correction for age, gender, IQ, and depression (r 2 ¼ 0.11, r ¼ 0.33, p ¼.002). 44 Our colleagues investigated the associations between plasma concentrations of folate, vitamin B 12, vitamin B 6, and homocysteine and scores on a battery of cognitive tests in 70 men, aged years, participating in the Normative Aging Study. 42 Lower folate and vitamin B 12 concentrations were associated with poorer spatial copying skills (r ¼ 0.25 and 0.35, respectively). In addition, plasma homocysteine concentration, which is inversely correlated with plasma folate and vitamin B 12 concentrations, was a stronger predictor of spatial copying performance than either vitamin (r ¼ 0.39, p ¼.0009). In a population-based study of 1270 subjects aged over 60 years, Morris et al. (2001) found that the odds of passing a simple memory (word recall) test were reduced by 70% for thcy > 13.7 mm (odds ratio 0.3; 95% CI ). 41 In a Scottish study of two cohorts born in 1921 and 1936, only the older cohort showed significant inverse correlations between homocysteine and performance on the Raven s Progressive Matrices (r ¼ 0.22), Block Design (r ¼ 0.27), and Digit Span tests (r ¼ 0.25). 45 The study by Bell et al. is notable for showing that elderly patients with depression who had lower cognitive screening test scores had significantly higher homocysteine concentrations than did either younger depression patients or elderly depression patients with normal cognitive screening test scores. 43 Several prospective studies reported an association between baseline homocysteine and subsequent cognitive decline in nondemented individuals. An early analysis of the relation of homocysteine to change in cognitive scores in the Rotterdam study failed to detect an association of baseline homocysteine and cognitive decline. 47 However, this early study used the relatively insensitive Mini Mental Status Examination and a short 3-year follow up. Subsequent analysis at after 6 years with more rigorous neuropsychological testing 48 revealed a highly significant association of baseline homocysteine with subsequent decline in discrete cognitive domains of attention and information processing and verbal learning and memory. In contrast, blood folate correlated only with Delayed Recall verbal learning and memory at baseline, and no correlations were observed for vitamin B 12. In a small study of 32 community adults greater than 65 years old in Wales, McCaddon et al. reported that high baseline thcy predicted follow-up cognitive scores on word recall and constructional praxis tests at a 5-year follow up, independent of age, sex renal function, B-vitamins, smoking, or hypertension. 49 Another recent longitudinal study of 499 people aged years, from the MacArthur Studies of Successful Aging, who were initially selected as high-functioning older adults, found that high baseline homocysteine and low folate, vitamin B 12, or vitamin B 6 status were each associated with worse baseline cognitive performance on a battery of tests that included confrontation naming, word recall, figure copying, and a test of conceptual reasoning. However, in the longitudinal follow-up, those in the lowest quartile of folate had a 1.6-fold increased risk of being in the worst quartile of cognitive decline, independent of homocysteine, whereas the association between homocysteine and cognitive decline was largely accounted for by low levels of folate. 50 HOMOCYSTIENE, BRAIN ATROPHY, AND WHITE-MATTER LESIONS Structural brain imaging has provided important information on the relation of homocysteine to functional cognitive dysfunction and to underlying cerebrovascular and neurodegenerative changes. The initial case control study of homocysteine and Alzheimer disease by Clarke et al. was prompted by the observation of rapid medial temporal lobe atrophy on x-ray computed tomography scans of patients with Alzheimer disease. 12 In a subsequent analysis of the same cohort, Clarke et al. reported a high correlation between thcy and leukoaraiosis on computed tomography scan of the brains of these patients. 51 The white-matter lesions were more pronounced in the deep white matter and were most prevalent in individuals with Alzheimer disease. Such associations appear to depend on the age, gender, and condition of the subjects examined. For example, in a cross-sectional study of homocysteine and brain atrophy, Sachdev 52 compared associations of white-matter hyperintensities with cognition in a case control study of stroke patients and of a healthy group of year-old adults. Contrary to expectations, general brain atrophy was not associated with homocysteine in stroke patients. Instead, the severity of deep whitematter hyperintensity was significantly correlated with homocysteine (r ¼ 0.167). Higher homocysteine was also associated with poorer measures of attention and executive function in both cases and controls (particularly on the Trails-B test). Overall cognitive performance was significantly correlated with white-matter hyperintensities, stroke number, and stroke volume, but homocysteine was only associated with stroke number and not the extent of lesions. In healthy yearold men and women, homocysteine showed a weak but significant correlation with the volume of deep whitematter hyperintensities (r ¼ 0.135), but again, it did not correlate with brain atrophy. These correlations were driven by male gender and, when analyzed separately, did not reach significance in the women, possibly because on average, women had more severe white-matter
4 HOMOCYSTEINE AND COGNITIVE FUNCTION/TROEN, ROSENBERG 207 damage but lower homocysteine concentrations. Another small study of psychogeriatric inpatients examined the relationship of homocysteine, folate, and vitamin B 12 with magnetic resonance imaging (MRI) markers of neuropathology. 53 Here, too, homocysteine was associated with severity of white-matter hyperintensity, but not with measures of brain volume or atrophy. Intriguingly, folate was associated with hippocampal and amygdalar volume and was negatively associated with whitematter damage, even though no individuals were clinically vitamin deficient. In the Rotterdam Brain Scan Study of 1077 men and women aged years, plasma homocysteine concentrations were associated with risk of severe deep and periventricular white-matter lesions and of silent brain infarcts in a cross-sectional analysis of MRI scans. 54 These lesions were three times more common in individuals in the top quintile of homocysteine values compared with the lowest four quintiles. The severity of the white-matter lesions increased with increasing homocysteine levels, and the association remained significant even after adjustment for atherosclerotic disease and the presence of silent infarcts. A subsequent study in the same cohort found region-specific atrophy in the cortex and hippocampus, but not in the amygdala. 55 Crosssectional neuropsychological test scores of participants were significantly associated with elevated plasma homocysteine with an adjusted difference of 0.26 (95% CI 0.37 to 0.14) for psychomotor speed, 0.13 (95% CI 0.27 to 0.01) for memory function, and 0.20 (95% CI 0.30 to 0.11) for global cognitive function for the top quintile, compared with the lower four quintiles of Hcy, respectively. These associations were not mediated by structural brain changes in white matter or global atrophy on MRI. 56 A similar analysis was conducted in the prospective Epidemiology of Vascular aging cohort (EVA). 57 Baseline homocysteine concentrations of more than 15 mm increased the risk of cognitive deterioration up to 4 years later by a factor of 2.7, on MMSE scores and the digit symbol coding and Trail making tests of executive function and attention, although in this cohort the Trails test did not reach significance. High homocysteine was also correlated with poor performance on cognitive tests in cross-sectional analyses. These results were not changed when the analyses were adjusted for MRI white-mater ratings, indicating that in this cohort, the cognitive impairment was not mediated by whitematter damage. In the Framingham Offspring study of 1539 men and women aged years (mean age years) who were free of clinical stroke, dementia, multiple sclerosis, and brain injury, higher plasma homocysteine concentrations were related to global brain atrophy as determined by MRI by measuring the ratio of the total brain volume to total cranial volume. 3 Greater atrophy was associated with poorer performance on neuropsychological tests of executive function and attention (including the Trails B test). Higher homocysteine was also directly related to poorer performance on tests of attention and concentration. CONCLUSION Most of the available evidence supports an association of homocysteine with a wide spectrum of central nervous system dysfunction and pathology. Moreover, the strong graded associations between plasma homocysteine levels and the risk of developing not only cerebrovascular disease, brain atrophy, and dementia but also cognitive decline over time in otherwise healthy older adults are consistent with a causal role for homocysteine in cognitive deterioration. Although the use of different tests and populations makes it difficult to compare studies directly, the weight of the evidence is consistent with an involvement of homocysteine in impairing discrete areas of cognitive function including visuospatial skills, memory, nonverbal intelligence, and speed of information processing. Interestingly, these patterns of cognitive deficits are consistent with what would be predicted to result from a subcortical vascular pathology. Nevertheless, such compelling epidemiological data cannot establish causality, and although there are plausible mechanisms to account for the associations, it remains to be demonstrated whether elevated homocysteine mediates or is merely an indicator of metabolic abnormalities that accelerate brain aging. Although epidemiological studies can try to isolate the relationships of homocysteine to functional and structural measures of central nervous system integrity from those of its metabolic determinants, homocysteine is never biologically independent of its determinants, and any rise in plasma homocysteine is preceded by a metabolic or physiologic change. Isolating homocysteine as cause or effect requires the use of experimental models. 58 Identifying brain lesions and cognitive domains that are specifically determined by homocysteine in human studies may prove similarly challenging. Even so, the finding that high baseline homocysteine predicts incident dementia long before the manifestation of cognitive decline 4 indicates that homocysteine is an early marker for the incipient disease process. Ultimately, clinical trials of B-vitamin supplementation will have to determine whether homocysteine lowering can prevent or slow the progression of age-related cognitive decline. The solution to this challenge is eagerly anticipated. ACKNOWLEDGMENTS This work was supported by a grant from the Alzheimer s Association (NIRG ) and by the U.S. Department of Agriculture under cooperative
5 208 SEMINARS IN VASCULAR MEDICINE/VOLUME 5, NUMBER Q2 Q3 Q4 Q5 agreement No Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the U.S. Department of Agriculture. REFERENCES 1. Katzman R, Kawas C. The epidemiology of dementia and Alzheimer disease. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer Disease. New York: Rave Press; 1994 Q2 2. Smith AD. Homocysteine, B vitamins and cognitive deficit in the elderly.. Am J Clin Nutr 2002 Q3 ;75: Beiser A, Au R, DeCarli C, et al. Higher levels of plasma homocysteine are associated with subsequent lower brain volume and poorer performance on tests of attention and concentration: the Framingham offspring study. The 8th International Conference on Alzheimer s Disease and Related Disorders. Stockholm, Sweden, 2002 Q4 4. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer s disease. N Engl J Med 2002;346: Selhub J, Bagley LC, Miller J, Rosenberg IH. B vitamins, homocyseine, and neurocognitive function in the elderly. Am J Clin Nutr 2000;71:614S 620S 6. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969 Q5 ;56: Yoo JH, Chung CS, Kang SS. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke 1998;29: Bostom AG, Rosenberg IH, Silbershatz H, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999;131: Brattstrom LE, Hardevo JE, Hultverg BL. Moderate homocysteinemia a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984;15: Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274: Fassbender K, Mielke O, Bertsch T, Nafe B, Froschen S, Hennerici M. Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999;353: Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002;59: Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55: Moller J, Nielsen GM, Tvedegaard KC, Andersen NT, Jorgensen PE. A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest 2000;60: Alfthan G, Pekkanen J, Jauhiainen M, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994;106: Fallon UB, Elwood P, Ben-Shlomo Y, Ubbink JB, Greenwood R, Smith GD. Homocysteine and ischaemic stroke in men: the Caerphilly study. J Epidemiol Community Health 2001;55: Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 1994;25: Bots ML, Launer LJ, Lindemans J, et al. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 1999;159: Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346: Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA 1999;281: Casas J, Bautista L, Smeeth L, Sharma P, Hingorani A. Homocysteine and stroke: evidence on a causal link from mendelian randomization. Lancet 2005;365: Joosten E, Lesaffre E, Riezler R, et al. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer s disease? J Gerontol A Biol Sci Med Sci 1997;52:M76 M McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998;13: Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 2002;58: Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004;62: Ravaglia G, Forti P, Maioli F, et al. Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment. Mech Ageing Dev 2000;121: Storey SG, Suryadevara V, Aronow WS, Ahn C. Association of plasma homocysteine in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascular disease. J Gerontol A Biol Sci Med Sci 2003;58:M1135 M Religa D, Styczynska M, Peplonska B, et al. Homocysteine, apolipoprotein E and methylenetetrahydrofolate reductase in Alzheimer s disease and mild cognitive impairment. Dement Geriatr Cogn Disord 2003;16: Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement Geriatr Cogn Disord 1999;10: Leblhuber F, Walli J, Artner-Dworzak E, et al. Hyperhomocysteinemia in dementia. J Neural Transm 2000;107: Nilsson K, Gustafson L, Hultberg B. Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer s disease. Int J Geriatr Psychiatry 2004;19: de la Torre JC. Cerebromicrovascular pathology in Alzheimer s disease compared to normal aging. Gerontology 1997;43: Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999;13:S115 S Moody DM, Brown WR, Challa VR, Ghazi-Birry HS, Reboussin DM. Cerebral microvascular alterations in aging,
6 HOMOCYSTEINE AND COGNITIVE FUNCTION/TROEN, ROSENBERG 209 leukoaraiosis, and Alzheimer s disease. Ann N Y Acad Sci 1997;826: Morris JH. Vascular dementia. In: Esiri MM, Morris JH, eds. The Neuropathology of Dementia. Cambridge: Cambridge University Press; 1997: O Brien MD. Vascular dementia is underdiagnosed. Arch Neurol 1988;45: Nagy Z, Esiri MM, Jobst KA, et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 1997;56: Pollak RD, Pollak A, Idelson M, Bejarano-Achache I, Doron D, Blumenfeld A. The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia. J Am Geriatr Soc 2000;48: Fassbender K, Mielke O, Bertsch T, Nafe B, Fröschen S, Hennerici M. Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999;353: Brookmeyer R, Curriero FC. Survival curve estimation with partial non-random exposure information. Stat Med 2002; 21: Morris MS, Jacques PF, Rosenberg IH, Selhub J. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001;73: Riggs KM, Spiro Ar, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996;63: Bell IR, Edman JS, Selhub J, et al. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand 1992;86: Budge M, Johnston C, Hogervorst E, et al. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann N Y Acad Sci 2000;903: Duthie SJ, Whalley LJ, Collins AR, Leaper S, Berger K, Deary IJ. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002;75: Miller JW, Green R, Ramos MI, et al. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2003;78: Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol 1999;150: Teunissen CE, Blom AH, Van Boxtel MP, et al. Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. J Nutr Health Aging 2003;7: McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001;12: Kado D, Karlamangla A, Huang M, et al. Homocysteine versus the vitamins folate, B6 and B12 as predictors of cognitive function and cognitive decline in older high functioning adults: MacArthur studies of successful aging. Am J Med 2005: In press 51. Clarke R, Joachim C, Esiri M, et al. Leukoaraiosis at presentation and disease progression during follow-up in histologically confirmed cases of dementia. Ann N Y Acad Sci 2000;903: Sachdev P. Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 2004;226: Scott TM, Tucker KL, Bhadelia A, et al. Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. Am J Geriatr Psychiatry 2004;12: Vermeer SE, van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 2002;51: den Heijer T, Vermeer SE, Clarke R, et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003;126: Prins ND, Den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002;59: Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003;53: Troen AM, Lutgens E, Smith DE, Rosenberg IH, Selhub J. The atherogenic effect of excess methionine intake. Proc Natl Acad Sci USA 2003;100:
Serum Levels of Homocysteine, Vitamin B12, and Folic Acid in Patients with Alzheimer s Disease
IJMS Vol 34, No 3, September 2009 Original Article Serum Levels of Homocysteine, Vitamin B12, and Folic Acid in Patients with Alzheimer s Disease Fariba Karimi 1, Afshin Borhani Haghighi 2, Payman Petramfar
More informationHigh homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study 1 4
See corresponding editorial on page 493. See corresponding CME exam on page 712. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study
More informationHomocysteine and ischaemic stroke in men: the Caerphilly study
J Epidemiol Community Health 2001;55:91 96 91 Homocysteine and ischaemic stroke in men: the Caerphilly study U B Fallon, P Elwood, Y Ben-Shlomo, J B Ubbink, R Greenwood, G Davey Smith Department of Social
More informationThe New England Journal of Medicine PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR DEMENTIA AND ALZHEIMER S DISEASE. Subjects
PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR DEMENTIA AND ALZHEIMER S DISEASE SUDHA SESHADRI, M.D., ALEXA BEISER, PH.D., JACOB SELHUB, PH.D., PAUL F. JACQUES, SC.D., IRWIN H. ROSENBERG, M.D., RALPH B. D AGOSTINO,
More informationA Controlled Trial of Homocysteine Lowering and Cognitive Performance
The new england journal of medicine original article A Controlled Trial of Homocysteine Lowering and Cognitive Performance Jennifer A. McMahon, Ph.D., Timothy J. Green, Ph.D., C. Murray Skeaff, Ph.D.,
More informationPlasma Total Homocysteine and Memory in the Elderly: The Hordaland Homocysteine Study
Plasma Total Homocysteine and Memory in the Elderly: The Hordaland Homocysteine Study Eha Nurk, MD, 1 Helga Refsum, MD, 1,2 Grethe S. Tell, PhD, 3,4 Knut Engedal, MD, PhD, 5 Stein E. Vollset, MD, DrPH,
More informationLow vitamin B-12 status and risk of cognitive decline in older adults 1 3
Low vitamin B-12 status and risk of cognitive decline in older adults 1 3 Robert Clarke, Jacqueline Birks, Ebba Nexo, Per M Ueland, Joern Schneede, John Scott, Anne Molloy, and John Grimley Evans ABSTRACT
More informationTHE PREVALENCE OF ALZHEImer
ORIGINAL CONTRIBUTION Relation of Higher Folate Intake to Lower Risk of Alzheimer Disease in the Elderly José A. Luchsinger, MD; Ming-Xin Tang, PhD; Joshua Miller, PhD; Ralph Green, MD; Richard Mayeux,
More informationChapter 11 summary definitief ineke brands.indd :57:59
chapter 11 Summary chapter 11 Both type 1 and type 2 diabetes mellitus are associated with altered brain function, a complication referred to as diabetic encephalopathy. Previous studies have shown that
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Cognitive impairment evaluated with Vascular Cognitive Impairment Harmonization Standards in a multicenter prospective stroke cohort in Korea Supplemental Methods Participants From
More informationB-vitamins and prevention of dementia
Proceedings of the Nutrition Society (8), 67, 75 81 g The Author 8 DOI:1.117/S2966518646 The Summer Meeting of the Nutrition Society, hosted by the Irish Section, was held at the University of Ulster,
More informationORIGINAL CONTRIBUTION. Folate, Vitamin B 12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
ORIGINAL CONTRIBUTION Folate, Vitamin B 12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease Robert Clarke, MD; A. David Smith, DPhil; Kim A. Jobst, DM; Helga Refsum, MD; Lesley Sutton,
More informationByung-Ok Choi, M.D., Yong Seong Kim, Ph.D.*, Ok-Joon Kim, M.D., Jung-Ho Seo, M.D., Nam-Keun Kim, Ph.D.
Hyperhomocysteinemia as an Independent Risk Factor for Silent Brain Infarction - Inverse Correlation with Folate in Patients with MTHFR 677TT Genotype - Byung-Ok Choi, M.D., Yong Seong Kim, Ph.D.*, Ok-Joon
More informationThe Primary Care Guide To Understanding The Role Of Diabetes As A Risk Factor For Cognitive Loss Or Dementia In Adults
The Primary Care Guide To Understanding The Role Of Diabetes As A Risk Factor For Cognitive Loss Or Dementia In Adults. Introduction Glucose intolerance is common in older individuals and this metabolic
More informationORIGINAL INVESTIGATION. Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the Elderly
Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the Elderly The Rotterdam Study ORIGINAL INVESTIGATION Michiel L. Bots, MD, PhD; Lenore J. Launer, PhD; Jan Lindemans, PhD; Arno
More informationSeptember 26 28, 2013 Westin Tampa Harbour Island. Co-sponsored by
September 26 28, 2013 Westin Tampa Harbour Island Co-sponsored by From Brains at Risk to Cognitive Dysfunction: The Role of Vascular Pathology Ralph Sacco, MD, MS, FAHA, FAAN Miller School of Medicine
More informationORIGINAL CONTRIBUTION. Dietary Folate and Vitamin B 12 Intake and Cognitive Decline Among Community-Dwelling Older Persons
ORIGINAL CONTRIBUTION Dietary Folate and Vitamin B 12 Intake and Cognitive Decline Among Community-Dwelling Older Persons Martha Clare Morris, ScD; Denis A. Evans, MD; Julia L. Bienias, ScD; Christine
More informationMild to moderately elevated plasma total
The Journal of Prevention of Alzheimer s Disease - JPAD Volume 4, Number 3, 2017 Original Resesarch B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive
More informationMild Cognitive Impairment (MCI)
October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine
More informationNIH Public Access Author Manuscript Alzheimers Dement. Author manuscript; available in PMC 2012 June 15.
NIH Public Access Author Manuscript Published in final edited form as: Alzheimers Dement. 2005 July ; 1(1): 11 18. doi:10.1016/j.jalz.2005.06.001. Reduced risk of Alzheimer s disease with high folate intake:
More informationErin Cullnan Research Assistant, University of Illinois at Chicago
Dr. Moises Gaviria Distinguished Professor of Psychiatry, University of Illinois at Chicago Director of Consultation Liaison Service, Advocate Christ Medical Center Director of the Older Adult Program,
More informationNeurocognitive outcomes in homocysteine lowering trials
Neurocognitive outcomes in homocysteine lowering trials خفض الهوموسيستي ين والتا ثيرات العصبيه -الا دراكيه Aron Troen, DPhil Director, Nutrition and Brain Health Laboratory Institute of Biochemistry Food
More informationSTROKE is the third leading cause of death in the United
Journal of Gerontology: MEDICAL SCIENCES 2003, Vol. 58A, No. 6, 531 535 Copyright 2003 by The Gerontological Society of America Cognitive Function and Incidence of Stroke in Older Mexican Americans Glenn
More informationSupplementary Online Content
Supplementary Online Content Hooshmand B, Magialasche F, Kalpouzos G, et al. Association of vitamin B, folate, and sulfur amino acids with brain magnetic resonance imaging measures in older adults: a longitudinal
More informationHomocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study
Clin Chem Lab Med 2005;43(10):1101 1106 2005 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2005.192 2005/203 Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse
More informationScope of the talk. Riboflavin, other dairy B vitamins and cardiovascular health. Epidemiology of milk consumption and CVD
Riboflavin, other dairy B vitamins and cardiovascular health Professor Hilary J Powers University of Sheffield United Kingdom Scope of the talk Importance of dairy products to B vitamin intakes Epidemiological
More informationClinical Study Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer s and Cognitively Normal Elderly
Hindawi Publishing Corporation Depression Research and Treatment Volume 2011, Article ID 396958, 6 pages doi:10.1155/2011/396958 Clinical Study Depressive Symptom Clusters and Neuropsychological Performance
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/42751 holds various files of this Leiden University dissertation Author: Foster-Dingley, J.C. Title: Blood pressure in old age : exploring the relation
More informationRecent publications using the NACC Database. Lilah Besser
Recent publications using the NACC Database Lilah Besser Data requests and publications Using NACC data Number of requests by year Type 2009 2010 2011 2012 2013 2014 2015 Data files* 55 85 217 174 204
More informationHomocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus Study 1 3
Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus Study 1 3 Simon P Mooijaart, Jacobijn Gussekloo, Marijke Frölich, Jelle Jolles, David J Stott,
More informationFour Tissue Segmentation in ADNI II
Four Tissue Segmentation in ADNI II Charles DeCarli, MD, Pauline Maillard, PhD, Evan Fletcher, PhD Department of Neurology and Center for Neuroscience, University of California at Davis Summary Table of
More informationPost Stroke Cognitive Decline
Post Stroke Cognitive Decline Deborah A. Levine, MD, MPH Departments of Medicine & Neurology University of Michigan deblevin@umich.edu Presenter Disclosure Information Deborah A. Levine, MD, MPH Post Stroke
More informationFolate, vitamin B 6, and vitamin B 12 are cofactors in
Research Letters Dietary Folate and Vitamin B 6 and B 12 Intake in Relation to Mortality From Cardiovascular Diseases Japan Collaborative Cohort Study Renzhe Cui, MD; Hiroyasu Iso, MD; Chigusa Date, MD;
More informationPlasma homocysteine concentrations in a Belgian school-age population 1 3
Plasma homocysteine concentrations in a Belgian school-age population 1 3 Corinne De Laet, Jean-Claude Wautrecht, Daniel Brasseur, Michèle Dramaix, Jean-Marie Boeynaems, Jean Decuyper, and André Kahn ABSTRACT
More informationHomocysteine and cognitive performance: Modification by the ApoE genotype
The University of Maine DigitalCommons@UMaine Maine-Syracuse Longitudinal Papers Maine-Syracuse Longitudinal Study 2008 Homocysteine and cognitive performance: Modification by the ApoE genotype Merrill
More informationAbundant evidence has accumulated supporting the association
Folate, Vitamin B 6, and B 12 Intakes in Relation to Risk of Stroke Among Men Ka He, MD; Anwar Merchant, DMD; Eric B. Rimm, ScD; Bernard A. Rosner, PhD; Meir J. Stampfer, MD; Walter C. Willett, MD; Alberto
More informationHyperhomocysteinaemia in Black patients with cerebral thrombosis
Q J Med 1997; 90:635-639 Hyperhomocysteinaemia in Black patients with cerebral thrombosis R. DELPORT 1, J.B. UBBINK\ W.J.H. VERMAAK 1, H. ROSSOUW 1, P.J. BECKER 2 andj. JOUBERT 3 * From the ^Department
More informationHow does exercise benefit people at risk for dementia?
How does exercise benefit people at risk for dementia? Neva J. Kirk-Sanchez, PhD, PT University of Miami Miller School of Medicine Department of Physical Therapy Brain processes that show greatest rates
More informationORIGINAL CONTRIBUTION. Risk Factors for Mild Cognitive Impairment. study the Cardiovascular Health Study Cognition Study.
Risk Factors for Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study Part 2 ORIGINAL CONTRIBUTION Oscar L. Lopez, MD; William J. Jagust; Corinne Dulberg, PhD; James T. Becker,
More informationHomocysteine in Alzheimer`s Disease and Related Disorders
Homocysteine in Alzheimer`s Disease and Related Disorders By Prof. Doaa Hamed Hewedi Professor of Psychiatry, Institute of psychiatry, Ain shams University Introduction -Worldwide, most people with AD
More informationNeuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia
86 Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia Pai-Yi Chiu 1,3, Chung-Hsiang Liu 2, and Chon-Haw Tsai 2 Abstract- Background: Neuropsychiatric profile
More informationHomocysteine, small-vessel disease, and atherosclerosis An MRI study of 825 stroke patients
Homocysteine, small-vessel disease, and atherosclerosis An MRI study of 825 stroke patients Sang-Beom Jeon, MD, PhD Dong-Wha Kang, MD, PhD Jong S. Kim, MD, PhD Sun U. Kwon, MD, PhD Correspondence to Dr.
More informationREVIEW ARTICLE. Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease Causal or Casual? REVIEW ARTICLE William G. Christen, ScD; Umed A. Ajani, MBBS; Robert J. Glynn, ScD; Charles H. Hennekens, MD
More informationP H Whincup, H Refsum, I J Perry, R Morris, M Walker, L Lennon, A Thomson, P M Ueland, S B J Ebrahim
448 Cardiovascular Research Unit, Department of Primary Care and Population Sciences, Royal Free Hospital School of Medicine, London NW3 2PF, UK P H Whincup R Morris M Walker L Lennon A Thomson S B J Ebrahim
More informationVitamin B-12 and cognition in the elderly 1 4
Vitamin B-12 and cognition in the elderly 1 4 A David Smith and Helga Refsum ABSTRACT Vitamin B-12 deficiency is often associated with cognitive deficits. Here we review evidence that cognition in the
More informationThe Link Between Cardiovascular Disease and Dementia Victoria Porter
The Link Between Cardiovascular Disease and Dementia Victoria Porter Medscape Cardiology 8(2), 2004. 2004 Medscape Posted 08/25/2004 Introduction Cardiovascular disease (CVD) and dementia often occur concomitantly,
More informationBrain tissue and white matter lesion volume analysis in diabetes mellitus type 2
Brain tissue and white matter lesion volume analysis in diabetes mellitus type 2 C. Jongen J. van der Grond L.J. Kappelle G.J. Biessels M.A. Viergever J.P.W. Pluim On behalf of the Utrecht Diabetic Encephalopathy
More informationThe current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease
The current state of healthcare for Normal Aging, g, Mild Cognitive Impairment, & Alzheimer s Disease William Rodman Shankle, MS MD FACP Director, Alzheimer s Program, Hoag Neurosciences Institute Neurologist,
More informationORIGINAL CONTRIBUTION. Association of Alcohol Consumption With Brain Volume in the Framingham Study
ORIGINAL CONTRIBUTION Association of Alcohol Consumption With Brain Volume in the Framingham Study Carol Ann Paul, MS; Rhoda Au, PhD; Lisa Fredman, PhD; Joseph M. Massaro, PhD; Sudha Seshadri, MD; Charles
More informationFolate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women
Original Contributions Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women Eric B. Rimm, ScD; Walter C. Willett, MD, DrPH; Frank B. Hu, MD, PhD; Laura
More informationB-Vitamins and the Ageing Brain
B-Vitamins and the Ageing Brain Helene McNulty PhD RD MRIA Director of the Northern Ireland Centre for Food, Nutrition and Health (NICHE) ulster.ac.uk Presentation Outline The Ageing Brain Evidence linking
More informationDementia is characterized by a progressive deterioration
Review Synthèse Homocysteine and cognitive function in elderly Angeles Garcia, Katherine Zanibbi DOI:10.1503/cmaj.1031586 Abstract DEMENTIA IS HIGHLY PREVALENT AMONG ELDERLY PEOPLE, and projections show
More informationORIGINAL CONTRIBUTION. Association of Prior Stroke With Cognitive Function and Cognitive Impairment. stroke and cognitive impairment
ORIGINAL CONTRIBUTION Association of Prior Stroke With Cognitive Function and Cognitive Impairment A Population-Based Study David S. Knopman, MD; Rosebud O. Roberts, MBBCh; Yonas E. Geda, MD; Bradley F.
More informationVASCULAR COGNITIVE IMPAIRMENT/DEMENTIA SETTING THE STAGE
VASCULAR COGNITIVE IMPAIRMENT/DEMENTIA SETTING THE STAGE Larry B. Goldstein, MD, FAAN, FANA, FAHA University of Kentucky Lexington, KY Issues in the Diagnosis of Vascular Cognitive Impairment and Dementia
More informationThe Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging
The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging REBECCA F. GOTTESMAN, MD PHD ASSOCIATE PROFESSOR OF NEUROLOGY AND EPIDEMIOLOGY JOHNS HOPKINS UNIVERSITY OCTOBER 20, 2014 Outline
More informationKey Words: Hypertension, Blood pressure, Cognitive impairment, Age 대한신경과학회지 22 권 1 호
Seul-Ki Jeong, M.D., Hae-Sung Nam, M.D., Min-Ho Shin, M.D., Sun-Seok Kweon, M.D., Myong-Ho Son, M.D., Eui-Ju Son, M.D., Jae-Min Kim, M.D., Ki-Hyun Cho, M.D. Background: It has been reported that the association
More informationHOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE?
EAMA CORE CURRICULUM HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE? Sofia Duque Orthogeriatric Unit São Francisco Xavier Hospital Occidental Lisbon Hospital Center University Geriatric Unit, Faculty of
More informationStroke is the second most common cause of death in the
Association Between High Homocyst(e)ine and Ischemic Stroke due to Large- and Small-Artery Disease but Not Other Etiologic Subtypes of Ischemic Stroke John W. Eikelboom, MBBS, FRACP, FRCPA; Graeme J. Hankey,
More informationEstimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale
Estimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale Seong Hye Choi, M.D.*, Duk L. Na, M.D., Byung Hwa Lee, M.A., Dong-Seog Hahm, M.D., Jee Hyang Jeong, M.D.,
More informationSecrets of delaying aging and living disease free Part 1
Secrets of delaying aging and living disease free Part 1 Roman Pawlak, Ph.D, RD www.drromanpawlak.com Aging results in profound changes that effect all systems, organs and tissues. Pawlak R. Forever young.
More informationVascular dementia (VaD) is preceded by several years of
Cognitive Functioning in Preclinical Vascular Dementia A 6-Year Follow-Up Erika Jonsson Laukka, MSc; Sari Jones, MSc; Laura Fratiglioni, MD, PhD; Lars Bäckman, PhD Background and Purpose Recent studies
More informationSilent Cerebral Strokes: Clinical Outcomes and Management
Silent Cerebral Strokes: Clinical Outcomes and Management Nagaendran Kandiah Senior Consultant Neurologist, National Neuroscience Institute, Singapore Clinician Scientist, National Medical Research Council,
More informationNeuroReport 2011, 22: a Laboratory of Neuro Imaging, Department of Neurology, UCLA School of. Received 9 March 2011 accepted 13 March 2011
Ageing 391 Homocysteine effects on brain volumes mapped in 732 elderly individuals Priya Rajagopalan a, Xue Hua a, Arthur W. Toga a, Clifford R. Jack Jr b, Michael W. Weiner c,d and Paul M. Thompson a
More informationEffects of Moderate Alcohol Consumption on Cognitive Function in Women
original article Effects of Moderate Alcohol Consumption on Cognitive Function in Women Meir J. Stampfer, M.D., Jae Hee Kang, Sc.D., Jennifer Chen, M.P.H., Rebecca Cherry, M.D., and Francine Grodstein,
More informationT he concept of vascular cognitive covers a
28 PAPER Cognitive profile of subcortical ischaemic vascular disease H Jokinen, H Kalska, R Mäntylä, T Pohjasvaara, R Ylikoski, M Hietanen, O Salonen, M Kaste, T Erkinjuntti... J Neurol Neurosurg Psychiatry
More informationCOGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E
COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E Attention Problem Solving Language Cognitive Domains Decision Making Memory Reasoning The Cardiovascular Health Cognition Study shows higher S
More informationMetabolic syndrome is a constellation of cardiovascular
and Cognitive Decline in Elderly Latinos: Findings from the Sacramento Area Latino Study of Aging Study Kristine Yaffe, MD, wzk Mary Haan, DrPH, MPH, z Terri Blackwell, MA, # Elena Cherkasova, BA, Rachel
More informationUNIVERSA MEDICINA. Decreased serum homocysteine levels after micronutrient supplementation in older people
UNIVERSA MEDICINA September-December, 2010 Vol.29 - No.3 Decreased serum homocysteine levels after micronutrient supplementation in older people Pusparini* ABSTRACT *Department of Clinical Pathology, Medical
More informationRisk Factors for Vascular Dementia: A Hospital-Based Study in Taiwan
22 Risk Factors for Vascular Dementia: A Hospital-Based Study in Taiwan Jun-Cheng Lin 1,2, Wen-Chuin Hsu 1, Hai-Pei Hsu 1,2, Hon-Chung Fung 1, and Sien-Tsong Chen 1 Abstract- Background: In Taiwan, next
More informationOutline. Minority Issues in Aging Research. The Role of Research in the Clinical Setting. Why Participate in Research
Outline Minority Issues in Aging Research Mary Sano, Ph.D Mount Sinai School of Medicine Bronx Veterans Medical Research Center 130 West Kingsbridge Rd Bronx NY, 10468 Phone: 718 741-4228; Fax: 718 562-9120
More informationB Vitamins, Cognition, and Aging: A Review
Journal of Gerontology: PSYCHOLOGICAL SCIENCES 2001, Vol. 56B, No. 6, P327 P339 Copyright 2001 by The Gerontological Society of America B Vitamins, Cognition, and Aging: A Review Eva Calvaresi and Janet
More informationAssociation of White Matter Lesions and Lacunar Infarcts With Executive Functioning
American Journal of Epidemiology Advance Access published September 25, 2009 American Journal of Epidemiology ª The Author 2009. Published by the Johns Hopkins Bloomberg School of Public Health. All rights
More informationMandatory fortification of flour with folic acid
Mandatory fortification of flour with folic acid A brief update March 2014 A. David Smith and Helga Refsum, Universities of Oxford and Oslo For earlier more detailed reports see: Is folic acid good for
More informationSUPPLEMENTARY APPENDIX
Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 23 million people and more than 100,000 cases of dementia SUPPLEMENTARY APPENDIX Supplementary Methods Newcastle
More informationHyperhomocysteinemia is known to be an. Methylenetetrahydrofolate Reductase Gene Polymorphism. Relation to Blood Pressure and Cerebrovascular Disease
AJH 1998;11:1019 1023 BRIEF COMMUNICATIONS Methylenetetrahydrofolate Reductase Gene Polymorphism Relation to Blood Pressure and Cerebrovascular Disease Yukiko Nakata, Tomohiro Katsuya, Seiju Takami, Noriyuki
More informationLambros Messinis PhD. Neuropsychology Section, Department of Neurology, University of Patras Medical School
Lambros Messinis PhD Neuropsychology Section, Department of Neurology, University of Patras Medical School Type 2 Diabetes Mellitus is a modern day epidemic Age is a significant predictor of diabetes Males
More informationImpact of Dietary Factors and Inflammation on Cognition among Older Adults
The Journal of Prevention of Alzheimer s Disease - JPAD Volume 2, Number 4, 2015 Impact of Dietary Factors and Inflammation on Cognition among Older Adults E.P. Handing 1, B.J. Small 1, S.L. Reynolds 1,
More informationLow Diastolic Blood Pressure and High Blood Pressure Variability are Risk Factors for Cognitive Decline in Elderly Adults: A Case-Control Study
Low Diastolic Blood Pressure and High Blood Pressure Variability are Risk Factors for Cognitive Decline in Elderly Adults: A Case-Control Study Chia-Chi Chen 1, Jia-Fu Lee 2,3,, Yu-Lin Ko 4, Chun-Te Lee
More informationUNIVERSITY OF WESTERN ONTARIO
UNIVERSITY OF WESTERN ONTARIO Vladimir Hachinski, CM, MD, FRCPC, DSc Department of Clinical Neurological Sciences University of Western Ontario London, Ontario, Canada Vladimir.hachinski@lhsc.on.ca ALZHEIMER
More informationCEREBRAL SMALL VESSEL DISEASE
CEREBRAL SMALL VESSEL DISEASE IN DEMENTIA AND DEPRESSION A prospective population-based MRI study Acknowledgements The work presented in this thesis was conducted at the Department of Epidemiology & Biostatistics
More informationORIGINAL INVESTIGATION. Homocysteine and Ischemic Heart Disease. Results of a Prospective Study With Implications Regarding Prevention
ORIGINAL INVESTIGATION Homocysteine and Ischemic Heart Disease Results of a Prospective Study With Implications Regarding Prevention Nicholas J. Wald, DSc (Med), FRCP; Hilary C. Watt, MSc; Malcolm R. Law,
More informationInternational Forum on HIV and Rehabilitation Research
Neurocognitive screening and behavioural interventions for HIV-Associated Neurocognitive Disorders (HAND) International Forum on HIV and Rehabilitation Research Translating Research Evidence from the Canada-UK
More information/ffl. Cohort Study of Vitamin C Intake and Cognitive Impairment
/ffl American Journal of Epidemiology Copyright 1998 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 148, No. 1 Printed in U.S.A. A BRIEF ORIGINAL CONTRIBUTION
More informationDepartment of Neurology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
Print ISSN 1738-1495 / On-line ISSN 2384-0757 Dement Neurocogn Disord 2015;14(4):158-162 / http://dx.doi.org/10.12779/dnd.2015.14.4.158 ORIGINAL ARTICLE DND The Clinical Characteristics according to the
More informationCognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis. Background
Cognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis Victoria A Levasseur 1,2, Samantha Lancia 1, Gautam Adusumilli 1, Zach Goodman 1, Stuart D. Cook 3, Diego Cadavid 4, Robert T.
More informationAssociation of Vascular Risk Factors With Hippocampal Atrophy and Cognitive Impairment
Shimane J. Med. Sci., Vol.33 pp.1-8, 2016 Association of Vascular Risk Factors With Hippocampal Atrophy and Cognitive Impairment Takuya YAMAGUCHI 1,2), Keiichi ONODA 1), Shuhei YAMAGUCHI 1) 1) Department
More informationHomocysteine is an amino acid produced as an intermediate
CLINICAL REVIEW Homocysteine and Vascular Disease Christopher A. Friedrich, MD, PhD, and Daniel J. Rader, MD Homocysteine is an amino acid produced as an intermediate product in the metabolism of methionine,
More informationNonmotor complications in Parkinson
Original Article 305 Plasma Homocysteine Levels and Parkinson Disease: Disease Progression, Carotid Intima-media Thickness and Neuropsychiatric Complications Sharon Hassin-Baer, MD,* Oren Cohen, MD,* Eli
More informationNIH Public Access Author Manuscript Neuroreport. Author manuscript; available in PMC 2012 June 11.
NIH Public Access Author Manuscript Published in final edited form as: Neuroreport. 2011 June 11; 22(8): 391 395. doi:10.1097/wnr.0b013e328346bf85. Homocysteine effects on brain volumes mapped in 732 elderly
More informationHomocysteine as a Predictive Factor for Hip Fracture in Older Persons
The new england journal of medicine original article Homocysteine as a Predictive Factor for Hip Fracture in Older Persons Robert R. McLean, M.P.H., Paul F. Jacques, D.Sc., Jacob Selhub, Ph.D., Katherine
More informationDementia in Parkinson s disease:
Dementia in Parkinson s disease: A 20 year Prospective Neuropsychological Study Sydney Multicentre Study Associate Professor Wayne GJ Reid PhD FAPS 149 newly diagnosed community living Parkinson s Disease
More informationDementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology
Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language
More informationORIGINAL CONTRIBUTION. Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease
ORIGINAL CONTRIBUTION Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease The Framingham Heart Study Ernst J. Schaefer, MD; Vanina Bongard, MD, PhD; Alexa
More informationStatins and Cognition A Focus on Mechanisms
Statins and Cognition A Focus on Mechanisms Note: Deleted copyrighted graphs/tables are described In red text and source references are provided Disclosures: SPARCL Steering Committee and past consultant
More informationThe importance of cognitive ageing for understanding dementia
The importance of cognitive ageing for understanding dementia Archana Singh-Manoux, PhD 1,2,3 Mika Kivimäki, PhD 2 * Corresponding author & address: 1 Centre for Research in Epidemiology & Population Health,
More informationLife expectancy (LE) continues to rise dramatically, as reinforced by the latest
Minihane Nutrigenetics and Cognitive Health Anne Marie Minihane, PhD Life expectancy (LE) continues to rise dramatically, as reinforced by the latest Global Burden of Disease Study statistics published
More informationSilent Brain Infarcts and the Risk of Dementia and Cognitive Decline
The new england journal of medicine original article Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline Sarah E. Vermeer, M.D., Ph.D., Niels D. Prins, M.D., Tom den Heijer, M.D., Albert
More informationin a population with low plasma
518 Cardiology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey S L Tokgözoğlu E Atalar K Aytemir N Özer K Övünç S Kes Paediatric Genetics, Hacettepe University Faculty of Medicine M Alikaşifoğlu
More informationCHILDHOOD CANCER SURVIVAL STUDY CONCEPT PROPOSAL
Version: March 3, 2006 CHILDHOOD CANCER SURVIVAL STUDY CONCEPT PROPOSAL I- Title: Neurocognitive and Psychosocial Correlates of Adaptive Functioning in Survivors of Childhood Leukemia and Lymphoma. II-
More information